Iovance Biotherapeutics Inc (NASDAQ: IOVA) is -16.35% lower on its value in year-to-date trading and has touched a low of $5.57 and a high of $18.33 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IOVA stock was last observed hovering at around $6.25 in the last trading session, with the day’s loss setting it -0.06%.
Currently trading at $6.19, the stock is -6.09% and -19.03% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.74 million and changing -0.96% at the moment leaves the stock -34.03% off its SMA200. IOVA registered -18.98% loss for a year compared to 6-month loss of -33.08%. The firm has a 50-day simple moving average (SMA 50) of $7.645 and a 200-day simple moving average (SMA200) of $9.38325.
The stock witnessed a -17.36% gain in the last 1 month and extending the period to 3 months gives it a -41.38%, and is 5.27% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.97% over the week and 6.65% over the month.
Iovance Biotherapeutics Inc (IOVA) has around 557 employees, a market worth around $1.89B and $90.86M in sales. Profit margin for the company is -451.25%. Distance from 52-week low is 11.13% and -66.23% from its 52-week high. The company has generated returns on investments over the last 12 months (-48.76%).
with sales reaching $72.09M over the same period.The EPS is expected to grow by 33.27% this year, but quarterly earnings will post 13,570.57% year-over-year. Quarterly sales are estimated to grow 14,857.12% in year-over-year returns.
Iovance Biotherapeutics Inc (IOVA) Top Institutional Holders
389.0 institutions hold shares in Iovance Biotherapeutics Inc (IOVA), with institutional investors hold 89.47% of the company’s shares. The shares outstanding are 304.62M, and float is at 247.03M with Short Float at 25.09%. Institutions hold 88.95% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 25.95 million shares valued at $208.12 million. The investor’s holdings represent 9.7478% of the IOVA Shares outstanding. As of 2024-06-30, the second largest holder is PERCEPTIVE ADVISORS LLC with 25.93 million shares valued at $207.98 million to account for 9.7412 of the shares outstanding. The other top investors are MHR FUND MANAGEMENT LLC which holds 24.0 million shares representing 9.014% and valued at over $192.46 million, while BLACKROCK INC. holds 7.9728 of the shares totaling 21.23 million with a market value of $170.23 million.
Iovance Biotherapeutics Inc (IOVA) Insider Activity
The most recent transaction is an insider sale by Maynard Ryan D, the company’s Director. SEC filings show that Maynard Ryan D sold 50,000 shares of the company’s common stock on Nov 12 ’24 at a price of $10.06 per share for a total of $0.5 million. Following the sale, the insider now owns 7500.0 shares.
Still, SEC filings show that on Feb 20 ’24, MCPEAK MERRILL A (Director) acquired 250,000 shares at an average price of $9.15 for $2.29 million. The insider now directly holds 320,150 shares of Iovance Biotherapeutics Inc (IOVA).
